These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15811864

  • 1. Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
    Osman F, Qaisar S, Pitt M.
    Circulation; 2005 Apr 05; 111(13):e176-7; author reply e176-7. PubMed ID: 15811864
    [No Abstract] [Full Text] [Related]

  • 2. Landmarks: examining the foundation for GP IIb/IIIa inhibitors in PCI.
    J Invasive Cardiol; 2002 Dec 05; 14(12):776-9. PubMed ID: 12537005
    [No Abstract] [Full Text] [Related]

  • 3. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD.
    Circulation; 2004 Oct 05; 110(14):1960-6. PubMed ID: 15451795
    [Abstract] [Full Text] [Related]

  • 4. [Percutaneous coronary intervention in diabetic patients].
    Lablanche JM, Rosey G, Zoubidi M, Sudre A.
    Bull Acad Natl Med; 2005 Feb 05; 189(2):249-56. PubMed ID: 16114856
    [Abstract] [Full Text] [Related]

  • 5. The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts.
    D'Agate DJ, Patel S, Coppola JT, Ambrose JA.
    J Invasive Cardiol; 2004 Sep 05; 16(9):500-3. PubMed ID: 15353833
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E.
    J Thorac Cardiovasc Surg; 2005 Aug 05; 130(2):512-9. PubMed ID: 16077421
    [Abstract] [Full Text] [Related]

  • 11. Multivessel coronary artery disease: how do we treat it?
    Sharma S.
    Timely Top Med Cardiovasc Dis; 2007 Jul 09; 11():E15. PubMed ID: 18297143
    [No Abstract] [Full Text] [Related]

  • 12. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS, Syros G, Dangas G.
    Angiology; 2008 Jul 09; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular disease in diabetes.
    Sigal R, Malcolm J, Meggison H.
    Clin Evid; 2002 Jun 09; (7):498-520. PubMed ID: 12230676
    [No Abstract] [Full Text] [Related]

  • 14. [Percutaneous coronary intervention].
    Csapó K.
    Orv Hetil; 2005 Mar 27; 146(13):587-93. PubMed ID: 15856622
    [Abstract] [Full Text] [Related]

  • 15. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
    Tricoci P, Peterson ED.
    J Interv Cardiol; 2006 Oct 27; 19(5):449-55. PubMed ID: 17020570
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H, Kawai N, Umemoto T.
    Am J Cardiol; 2008 May 01; 101(9):1259-62. PubMed ID: 18435954
    [Abstract] [Full Text] [Related]

  • 17. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z, Mahoney EM, Spertus JA, Booth J, Nugara F, Kolm P, Stables RH, Weintraub WS.
    Am Heart J; 2006 Dec 01; 152(6):1153-60. PubMed ID: 17161069
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodés-Cabau J.
    J Invasive Cardiol; 2008 Mar 01; 20(3):99-104. PubMed ID: 18316823
    [Abstract] [Full Text] [Related]

  • 19. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevaliers B, DiMario C, Fajadeto J, Gitt A, Guagliumi G, Hillege HL, James S, Jüni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Berenger M, Boam A, Calle JP, Campo G, Carlier S, de Schepper J, Di Bisceglie G, Dobbels H, Farb A, Ghislain JC, Hellbardt S, ten Hoedt R, Isaia C, de Jong P, Lekehal M, LeNarz L, Mhullain FN, Nagai H, Patteet A, Paunovic D, Potgieter A, Purdy I, Raveau-Landon C, Ternstrom S, Van Wuytswinkel J, Waliszewski M, European Society of Cardiology.
    EuroIntervention; 2009 Jan 01; 4(4):427-36. PubMed ID: 19284063
    [No Abstract] [Full Text] [Related]

  • 20. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.
    Circulation; 2008 Sep 09; 118(11):1146-54. PubMed ID: 18725490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.